Search
STRATA Skin Sciences Inc
SSKNAdd to Watchlist
0.190USD
0.0000.00%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
718.36KMarket Cap
LossP/E TTM
More Details of STRATA Skin Sciences Inc Company
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
STRATA Skin Sciences Inc Info
Ticker SymbolSSKN
Company nameStrata Skin Sciences Inc
IPO dateOct 28, 2005
CEORafaeli (Dolev)
Number of employees106
Security typeOrdinary Share
Fiscal year-endOct 28
Address5 Walnut Grove Drive, Suite 140
CityHORSHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19044
Phone12156193200
Websitehttps://www.strataskinsciences.com/
Ticker SymbolSSKN
IPO dateOct 28, 2005
CEORafaeli (Dolev)
Company Executives of STRATA Skin Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
--
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
20.00K
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
20.00K
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
20.00K
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
7.50K
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
2.00K
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
143.16K
--
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
20.00K
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
20.00K
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
20.00K
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
7.50K
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
2.00K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States (Country)
20.58M
67.06%
Other foreign
4.86M
15.84%
China
3.35M
10.93%
Middle East
1.90M
6.18%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Rafaeli (Dolev)
2.43%
Other
50.89%
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Rafaeli (Dolev)
2.43%
Other
50.89%
Shareholder Types
Shareholders
Proportion
Private Equity
24.49%
Investment Advisor/Hedge Fund
9.61%
Hedge Fund
8.27%
Corporation
6.21%
Individual Investor
3.76%
Investment Advisor
0.97%
Other
46.68%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
38
2.57M
43.62%
-87.87K
2025Q4
39
2.56M
43.55%
-107.46K
2025Q3
40
2.60M
49.33%
-171.52K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Accelmed Growth Partners Management Ltd
1.44M
24.49%
--
--
Sep 04, 2025
22NW, LP
537.00K
9.12%
--
--
Dec 31, 2025
Nantahala Capital Management, LLC
403.92K
6.86%
--
--
Dec 31, 2025
Lincoln Alternative Strategies LLC
365.85K
6.21%
+365.85K
--
Sep 03, 2025
Rafaeli (Dolev)
143.16K
2.43%
--
--
Dec 31, 2025
Renaissance Technologies LLC
63.83K
1.08%
-37.70K
-37.13%
Dec 31, 2025
Abante Asesores Gestión, S.G.I.I.C., S.A.
52.39K
0.89%
+52.39K
--
Dec 31, 2025
Allgeier (Christina L)
20.00K
0.34%
+20.00K
--
Dec 31, 2025
Geiger (Uri)
20.00K
0.34%
+20.00K
--
Dec 31, 2025
Gov (Shmuel)
20.00K
0.34%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
